Cargando…

Higher galectin-3 levels are independently associated with lower anxiety in patients with risk factors for heart failure

BACKGROUND: Galectin-3 promotes the proliferation of neural progenitor cells and is engaged in cell-cell adhesion, cell-matrix interactions, and macrophage activation. In addition, in patients with heart failure this carbohydrate-binding protein is a known prognostic marker for cardiovascular mortal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadlonova, Monika, Meyer, Thomas, Binder, Lutz, Wachter, Rolf, Edelmann, Frank, Herrmann-Lingen, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531142/ https://www.ncbi.nlm.nih.gov/pubmed/33024450 http://dx.doi.org/10.1186/s13030-020-00195-7

Ejemplares similares

The diagnostic and prognostic value of galectin‐3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST‐CHF study
por: Trippel, Tobias Daniel, et al.
Publicado: (2021)

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
por: Stahrenberg, Raoul, et al.
Publicado: (2010)

Motivational interviewing can support physical activity in elderly patients with diastolic heart failure: results from a pilot study
por: Schertz, Anna, et al.
Publicado: (2019)

Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2020)

Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial
por: Schnelle, Moritz, et al.
Publicado: (2021)

A short form of the General Self-Efficacy Scale (GSE-6): Development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at risk for heart failure
por: Romppel, Matthias, et al.
Publicado: (2013)

Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction—results from the DIAST‐CHF study
por: Stahrenberg, Raoul, et al.
Publicado: (2015)

Longitudinal association between N-terminal B-type natriuretic peptide, anxiety and social support in patients with HFpEF: results from the multicentre randomized controlled Aldo-DHF trial
por: Wilke, Marieke R., et al.
Publicado: (2023)

Heart transplantation in the era of COVID-19 pandemic: delirium, post-transplant depression, and visitor restrictions; the role of liaison and inpatient psychosomatic treatment—a case report
por: Sadlonova, Monika, et al.
Publicado: (2021)

Influence of baseline parameters on one‐year physical, mental, and health‐related quality of life in patients with heart failure and preserved ejection fraction
por: Fitz, Judith, et al.
Publicado: (2021)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trial
por: Herrmann-Lingen, Christoph, et al.
Publicado: (2020)

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
por: Nolte, Kathleen, et al.
Publicado: (2019)

Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study
por: Eidizadeh, Abass, et al.
Publicado: (2022)

Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study
por: Meyer, Thomas, et al.
Publicado: (2015)

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials
por: Werhahn, Stefanie M., et al.
Publicado: (2021)

Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2017)

Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex‐DHF pilot study
por: Trippel, Tobias Daniel, et al.
Publicado: (2016)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
por: Edelmann, Frank, et al.
Publicado: (2011)

Type D personality is a predictor of poor emotional quality of life in primary care heart failure patients independent of depressive symptoms and New York Heart Association functional class
por: Pedersen, Susanne S., et al.
Publicado: (2009)

Changes in treatment outcomes in patients undergoing an integrated psychosomatic inpatient treatment: Results from a cohort study
por: Sadlonova, Monika, et al.
Publicado: (2022)

Galectin-3 Serum Levels Are Independently Associated With Microalbuminuria in Chronic Heart Failure Outpatients
por: Iacoviello, Massimo, et al.
Publicado: (2015)

Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care
por: Koschack, Janka, et al.
Publicado: (2008)

Recognition of depression and anxiety and their association with quality of life, hospitalization and mortality in primary care patients with heart failure – study protocol of a longitudinal observation study
por: Eisele, Marion, et al.
Publicado: (2013)

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial
por: Düngen, Hans-Dirk, et al.
Publicado: (2011)

Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2010)

Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction
por: Luers, Claus, et al.
Publicado: (2010)

Is only-child status associated with a higher blood pressure in adolescence? An observational study
por: Pantke, Pauline Marie, et al.
Publicado: (2023)

Does Anxiety Affect Survival in Patients with Coronary Heart Disease?
por: Deter, Hans-Christian, et al.
Publicado: (2023)

Prognostic Value of Galectin-3 in Patients with Heart Failure
por: Bošnjak, Ivica, et al.
Publicado: (2015)

Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Galectin-3 as an Arrhythmogenic Predictive Marker for Heart Failure
por: Inoue, Keiko, et al.
Publicado: (2022)

Anxiety and Depression Levels in Parents after Counselling for Fetal Heart Disease
por: Erbas, Gizem Seyda, et al.
Publicado: (2023)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
por: Hashemi, Djawid, et al.
Publicado: (2020)

Heart failure awareness survey in Germany: general knowledge on heart failure remains poor
por: Zelenak, Christine, et al.
Publicado: (2017)

Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
por: Bahls, Martin, et al.
Publicado: (2019)

Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stages
por: Gerhardt, Louisa M. S., et al.
Publicado: (2022)

Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort
por: Hashemi, Djawid, et al.
Publicado: (2022)

Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure
por: Wachter, Rolf, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bm3tf1f7c8vkldvs9ufqv27de9